BIOTECHNOLOGY
Via the Chicago Tribune, a quick update on the progress of efforts at the USPTO to increase the speed of processing patents on nanotechnology. The conclusion in a nutshell: not much has happened.
Alan Gotcher, president and chief executive of Altair Nanotechnologies Inc. based in Reno,... read more
I am somewhat behind in my journal reading, so while this may be somewhat older news it was something that I wanted to share with the blog-o-sphere.
According to C&EN News (Chemical and Engineering News – November 7, 2005 issue), Standford University’s chemistry department... read more
from Bio-IT World:
CAMBIA, an independent, nonprofit institute based in Canberra, Australia, has set up BIOS (Biological Innovation for Open Society), which aims to extend the concepts of open source to biotechnology and other forms of innovation in biology. Last week CAMBIA introduced under an... read more
According to a Washington Post article, a human-animal hybrid is not patentable. Apparently a human hybrid is too close to a human. However, since the famous case of Diamond v. Chakrabarty, patents have been awarded to bacteria, yeast, and even animals. Chakrabarty's most famous quote on... read more
According to the Report on Law.com, Federal Court Invalidates Patent on Merck's No. 2 Drug:
The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., invalidated the patent for the once-a-week version of Merck's Fosamax, which dominates the market for osteoporosis drugs. Under the... read more
Russ over at Anything Under the Sun Made By Man recently posted Silver Lining to Fee Increases.
With the new legislation on fees for patents, comes some structural change. Now you can save 50% on filing fees by using electronic filing. While it requires learning the software, it may actually... read more
As many of you already know, the fee increase for the USPTO is official. As of last Wednesday, fees have increased again. That's two fee increases in a little over 2 months. President Bush signed the Consolidated Appropriations Act for 2005 on December 8, 2004, effective immediately.
Unfortunately... read more
Oklahoma Inventors Congress has a link to an article discussing the various aspects of intellectual property associated with ordinary businesses.
The article is on mondaq.com (free registration required). It is directed to U.K. readers, so don't take every detail as absolute truth.... read more
As PHOSITA previously reported, the USPTO has instituted a new classification for nanotechnology,
Class 977–nanotechnology, to provides for disclosures:
related to research and technology development at the atomic, molecular or macromolecular levels, in the length of scale of... read more
Outsourcing is a highly contentious and potentially cost-saving measure that is constantly in the news these days. Sending work off-shore (or, more specifically, outside the U.S.) provides a company the benefits of oftentimes highly educated labor forces that can complete ... read more
According to IP News Blog:
Last Monday, the United States Patent and Trademark Office announced a new registration category specifically for nanotechnology inventions.
The patent office's criteria for this category is that at least one dimension of an invention be less than 100 nanometers and the... read more
According to IP Law Bulletin, "A jury in Tennessee has ordered a subsidiary of medical device maker Medtronic to pay $400 million in punitive damages to the doctor who invented some of its spinal fusion technologies, bringing the total value of the verdict in the patent infringement lawsuit to more... read more
Congratulations to Receptor Logic Ltd. of Amarillo, Texas for winning a multi-million dollar Advanced Technology Program (ATP) grant from the National Institute of Standards and Technology.
Receptor Logic's proposal, entitled "TCR Mimics: A New Class of Antibodies Against HLA-peptide Complexes for... read more
Congratulations to our very own Kati McClatchey on the publication of her article entitled THE EFFECT OF THE �ONCO-MOUSE� DECISIONS ON THE EXCEPTION TO PATENTABILITY FOR �ANIMAL VARIETIES� UNDER THE EUROPEAN PATENT CONVENTION.
This article gives great a great review of the European patent... read more
Monsanto Company has won a key patent office battle regarding biotech-gene technology for the transformation of plants such as cotton. The decision by the U.S. Patent and Trademark Office that Monsanto's scientists were the first to invent this important discovery ends a 12-year patent... read more
- Next
- Prev